We have previously shown that concanavalin A (ConA) induction of suppressor cell activity is impaired in patients with lepromatous leprosy (LL). In this study, we demonstrated that the proportion of cells bearing the Leu8 antigen (associated with suppressor-inducer cells) is low in LL patients and tends to normalize during the erythema nodosum leprosum (ENL) episode. Antigen-induced suppressor cell function was evaluated by a two-stage assay. In the first stage, peripheral blood mononuclear cells (PBMC) were cultured for 5 days either in the presence of gamma-irradiated Mycobacterium leprae or in tissue culture medium as a control. In the second stage, mitomycin C-treated suppressor or control cells were added to phytohemagglutinin (PHA)-or ConA-stimulated autologous PBMC. The results indicate that the ability of M. keprae to induce suppressor activity was lower in LL patients than in patients with tuberculoid (TT) and intermediate clinical (BB, BL, BT) forms and Mycobacterium bovis BCG-immunized normal controls. In ENL patients, the percent suppression was between that of TT and normal individuals. M. leprae-induced suppression was more effective on ConAthan on PHA-triggered T-cell proliferation in all groups. In contrast, normal PBMC cultured for 5 days in RPMI 1640 medium (N-C) and cels from patients with leprosy (TT-C and LL-C) had effects of their own on PHA-or ConA-induced proliferation. LL-C depressed the response to ConA and enhanced PHA-induced proliferation of autologous cells. Conversely, TT-C reduced PHA-induced proliferation and increased the ConA response. Suppression of proliferation could not be overcome with exogenous interleukin-2 and was not related to the induction of the Tac antigen. The abilities of LL, TT, ENL, and normal cells to proliferate upon PHA or ConA stimulus were similar, indicating that the defect in the generation of in vitro suppression by M. Ieprae in LL patients occurred during the induction period (step 1 of assay).
Suppressor mechanisms are thought to play an important role in the susceptibility of patients with lepromatous leprosy (LL) to generalized Mycobacterium leprae infection (1, 2, 5, 25, 37) . However, the specificity and selectivity of the suppressor responses induced by M. leprae antigens remain open to discussion. Restricted specificity in the induction of suppression by M. leprae may be related to the method of evaluation used.
Most in vitro assays consist of one-stage reactions in which peripheral blood mononuclear cells (PBMC) are simultaneously exposed to M. leprae antigens and to other proliferative signals: mitogens (2, 17) , bacterial antigens (37) , and alloantigens (23) . Using this type of assay, Mehra et al. (16) (17) (18) reported that PBMC from LL and from borderline lepromatous (BL) patients but not from patients with the tuberculoid polar forms (TT, BT) or normal individuals could suppress concanavalin A (ConA) proliferation when cultured simultaneously with Dharmendra lepromin. These investigators have also tried to recover M. leprae-specific T-cell lines from the skin lesions of leprosy patients. T8 clones were obtained from both TT and LL patients, but only 33% of those expanded from LL skin lesions had suppressor activity in their system (20) .
Recently, Kaplan et al. (14) have shown that M. leprae antigens could suppress the proliferative responses of PBMC from LL patients as well as those of TT patients and of normal individuals that had never been exposed to M. leprae or M. leprae endemic areas.
A different approach was used by Stoner et al. (33) , who developed a two-stage assay to study subclinical infection in * Corresponding author.
healthy individuals with M. leprae contacts. The assay consisted of a first culture of PBMC with M. leprae (or other microbial antigens) for 7 days followed by a second culture in which antigen-primed cells were cocultured with fresh autologous cells triggered by M. leprae as well as by other microbial antigens. These investigators demonstrated strong suppressor responses in healthy individuals in contact with leprosy patients and challenged the hypothesis that M. leprae-induced suppression was restricted to the LL group. In addition, LL patients may have a more generalized defect in their ability to mount suppressor responses (1, 24, 30, 31) .
The complexity of the suppressor circuit has been recognized, and recently a role for inducer T cells (28, 35, 36) , some of them bearing the Leu8 antigen, has been proposed (12, 13) .
In this study, we analyzed the frequency of Leu8-positive cells in LL, TT, and normal Mycobacterium bovis BCGimmunized subjects and correlated the results with those of a functional two-stage assay for M. leprae-induced suppression. We showed that M. leprae-primed PBMC (3.6 x 107, 7.8 x 107, and 18 x 107 M. leprae per ml) (suppressor cells). The same batch of armadillo-derived, gamma-irradiated M. Ieprae obtained through the IMMLEP bank was used throughout the study. After three washes with RPMI (1,000 rpm), the cells were suspended in 0.5 ml of medium and 50 ,ug of mitomycin C (Sigma Chemical Co., St. Louis, Mo.) per ml was added to both control and suppressor cells to prevent cell division. After 30 min at 37°C, cells were washed three times and the cellular concentration was adjusted to 106 cells per ml in RPMI-AB.
(ii) Proliferation stage (second culture). Autologous PBMC that had been frozen at -80°C with RPMI-AB supplemented with 10% dimethyl sulfoxide were used as indicator cells in the second culture. A 50-,ul sample of indicator cells washed and resuspended in RPMI-AB at 106/ml were delivered into each well of microdilution plates (Falcon 3072) and were incubated with suppressor or control cells in a total volume of 100 ,ul. The suppression test was performed at a suppressor (or control)-to-indicator ratio of 1:1. PHA (10 the other clinical forms of the disease and in the normal group (Table 2) . Suppression induced by M. leprae was different according to the indicator cell system used. When ConA was used as the trigger in the second culture, differences between the responses of LL patients and the other groups were more marked. Addition of IL-2 (10 U/ml) to the cells proliferating in stage 2 did not alter the results. Expression of IL-2R after M. leprae induction was higher in both the LL and TT groups than in normal controls (Table 3 ) and bore no relationship to the degree of functional suppression observed; at different doses of M. leprae during the induction of suppression, this result was confirmed ( Fig. 1A and  B) . Recovery of suppressor activity of LL patients undergoing ENL episodes was also observed.
[3H]thymidine uptake of PBMC during second culture in the presence of control or M. leprae-primed PBMC. The relative effect of M. Ieprae-stimulated (S) or control precultured (C) autologous PBMC on PHA-or ConA-triggered proliferation was examined in detail in LL, ENL, and TT patients. The results shown in Fig. 2 indicate that although there was virtually no effect of normal precultured cells (N-C) on the subsequent PHA-or ConA-induced proliferation of autologous PBMC indicators, M. leprae-primed normal cells (N-S) strongly reduced ConA proliferation and, to a lesser extent, PHA proliferation. In the TT patient group, both TT-C and TT-S reduced the [3H]thymidine uptake of PHA-induced the proliferation of T cells during the second culture, we assayed the proportion of cells reacting with anti-IL-2R (anti-Tac). The results shown in Table 3 indicate that both LL and TT patients have higher numbers of Tac-positive cells than the controls at the beginning and after the induction of suppression with M. leprae. Nevertheless, while LL patients had similar numbers of Tac-positive cells as TT patients and twice as many as normal controls, their sup-,pressor activity was low.
PHA-and ConA-induced proliferation of T-lymphocyte subsets in leprosy patients and controls. Because M. lepraeinduced suppressor cells differed in their ability to inhibit the proliferation of autologous PBMC that were stimulated by PHA or ConA, the proportion of CD4 and CD8 T-lymphocyte subsets recovered after culture with PHA or ConA was evaluated in the different groups of patients. The results shown in Table 4 indicate that the proportions of T cells bearing the Leu3 or Leu2 surface marker were essentially the same in LL, TT, or normal individuals. After PHA culture, the Leu3 subset predominated in the three groups. Conversely, after ConA culture, Leu2-positive cells increased to a similar extent in all groups. a PBMC from LL (n = 3) or TT (n = 3) patients and normal controls (N; n = 3) were incubated for 3 days at 37°C with PHA (1/5,000) or ConA (5 ,ug/ml) in a humidified 5% Co2 atmosphere. After incubation, the cells were washed three times and incubated with MAb anti-Leu2a or anti-Leu3a as described in Materials and Methods. The percentage of positive cells was calculated, and the results are expressed as mean+ standard error.
DISCUSSION
Impaired ability of lymphocytes from LL patients to mount suppression after nonspecific stimulation with ConA has been shown previously by us and by others (1, 24, 30 ). ConA-induced suppressor cell function is the result of a complex process that involves T regulatory cells from different subsets as well as cells from nonlymphoid cell lines (21) . Therefore, the low suppressor response of LL patients could be due to an intrinsic defect in one or many of the components of the suppressor circuit. Recently, a subset of cells recognized by the Leu8 MAb has been described as an important component of the suppressor network (8, 13, 22, 28) . These cells may be related to the radiosensitive suppressor-inducer cells that belong to the CD4 differentiation group of lymphocytes (12, 35, 36) . MAb directed against the CD45R set of antigens (Lp220/2H4) are also thought to recognize suppressor-inducer cells (34) , but expression of these antigens appears to be related to the activation stage of the cells rather than to a particular subset of lymphocytes (32) . In contrast, the expression of Leu8 (p80) antigens is not linked to cell activation (11) . Furthermore, Damle et al. (7) have clearly shown that CD4+ CD45R-p80/Leu8+ cells are the only cells that can be activated by antigen to generate suppressor-inducer cells that modulate in turn the activity of CD8+ lymphocytes.
In this study, we determined the proportion of Leu8+ cells in LL, ENL, TT, and normal individuals and found strikingly low levels of Leu8+ cells in LL patients when they were compared with the other groups. LL patients undergoing ENL episodes recovered normal values of Leu8 ( Table  1) , indicating that the level of these cells could be influenced by the inflammatory process. In vitro activation of lymphocytes with lectins or with M. leprae antigens did not change significantly the proportion of Leu8-stained cells (Table 1) .
There is considerable controversy on the role of suppressor cells in the absence of a proliferative immune response of LL patients to M. leprae. Mehra et al. (16) (17) (18) proposed that there was high M. leprae-specific suppressor activity in LL compared with the other clinical forms of the disease. However, recent work of other groups suggests the contrary (14, 15, 33) . In fact, while some researchers suggest that the (9, 10) , others provide evidence for a more generalized status of anergy in LL (4, 6) .
In this study, we demonstrated that M. leprae can induce dose-dependent suppression in normal individuals, TT leprosy patients, and patients with the intermediate clinical forms (Fig. 1; Table 2 ). The ability of M. leprae to induce suppressor cell activity in LL patients (excluding those undergoing an ENL episode) was low. It has been suggested by others (14, 26) (Table 2) . Furthermore, the suppressor activity appeared to be unrelated to the proportion of cells bearing the Tac membrane antigen, known to be related to IL-2R (38) . As expected from continuous in vivo activation, the proportion of Tac-positive cells was higher both in LL and in TT patients than in normal controls. M. leprae stimulation increased their number in the three groups ( (21, 27) .
It is also unlikely that the different effects of M. lepraeprimed cells on PHA-stimulated or ConA-stimulated PBMC ( Fig. 1 and 2 ) were due to a defect in the ability of a given subset of LL-T or TT-T lymphocytes to proliferate after the lectin stimuli. There were no differences in the proportion of CD4 and CD8 cells activated by PHA or ConA in LL or TT patients or normal controls ( We analyzed the activity of spontaneous suppressor cells (PBMC-C) obtained after 5 days of culture in the absence of M. leprae and found that PBMC-C from leprosy patients behaved differently from PBMC-C from normal individuals (Fig. 2) . Thus, TT-C spontaneously suppressed the proliferation of cells that belonged mainly to the CD4 differentiation group (PHA proliferation), while LL-C suppressed ConAresponsive cells (many of them bearing CD8 antigens). Moreover, probably as a consequence of the balance of suppressor versus stimulatory mechanisms, ConA-induced proliferation was greater when TT-C were present in the second culture and PHA proliferation was enhanced by LL-C. These spontaneous suppressor cells (TT-C, LL-C) obtained after 5 day cultures were probably different from suppressor cells present in short-term cultures of LL PBMC (27) . After 24-h culture periods, PBMC from LL patients, mainly those undergoing ENL episodes, exerted spontaneous inhibition of PHA-induced proliferation via cyclooxigenase metabolites of arachidonic acid (S. de la Barrera, R. Valdez, L. M. Balinia, and M. del C. Sasiain, Medicina (Buenos Aires) 47:630, 1987).
The results of this study suggest that there is a link between the reduction of Leu8-positive cells and the low functional suppressor response of LL PBMC after M. leprae stimulation. We believe that the low frequency of Leu8-positive cells in LL patients is a clue to the inability of LL PBMC to generate specific and nonspecific suppression of T-cell proliferation and may be related to the inability of LL patients to resist M. leprae.
